Jeil Pharma Holdings Inc
Символ: 002620.KS
KSC
10150
KRWПазарна цена днес
-19.7784
Съотношение P/E
0.0930
Коефициент PEG
155.81B
MRK Cap
- 0.00%
Доходност на DIV
Jeil Pharma Holdings Inc (002620-KS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 234375.12 | 59131 | 53402.7 | 47223.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 86457.8 | 22092.4 | 18643.2 | 18642.9 | |||||||||||||||||
balance-sheet.row.net-receivables | 782964.19 | 198695.1 | 181304.5 | 167949 | |||||||||||||||||
balance-sheet.row.inventory | 531549.74 | 125280.1 | 113265.7 | 114242.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 11507.57 | 1421 | 4943.5 | 5728.2 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1560396.62 | 384527.2 | 352916.4 | 335143.7 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 921883.08 | 228862.4 | 233120.1 | 212965.1 | |||||||||||||||||
balance-sheet.row.goodwill | 265259.92 | 44862.3 | 73465.9 | 151801.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 48297.94 | 13093.2 | 9472.3 | 3781.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 313557.86 | 57955.5 | 82938.2 | 155582.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | 389896.62 | 199929.7 | 67118.8 | 60379.6 | |||||||||||||||||
balance-sheet.row.tax-assets | -64449.59 | 5448.7 | 188.5 | 1451.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 470872.57 | 3273.5 | 129395.1 | 126898.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 2031760.54 | 495469.8 | 512760.6 | 557277.7 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.account-payables | 636258.45 | 154050 | 162967.4 | 159388.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 600673.06 | 161332.5 | 119087.3 | 94964.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 3382.6 | 774.7 | 1159.8 | 684.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 49892.41 | 10500 | 17477 | 20107.5 | |||||||||||||||||
Deferred Revenue Non Current | 9246.16 | 1198 | 0 | 36229.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 145216.43 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 205023.86 | 95305.2 | 74662 | 17971.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 262882.12 | 65175.1 | 87379.8 | 94084.1 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 6892.95 | 1198 | 1869.2 | 2383.2 | |||||||||||||||||
balance-sheet.row.total-liab | 1882055.08 | 477810.9 | 445884.6 | 392107.7 | |||||||||||||||||
balance-sheet.row.preferred-stock | 43492.24 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 31946.71 | 7986.7 | 7986.7 | 7986.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 309763.33 | -14357.5 | 98244.6 | 172151.3 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 477369.96 | 152732.4 | 226471 | 226109.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 498974.16 | 173099.5 | 5062.4 | 5482.9 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1361546.4 | 319461.2 | 337764.7 | 411730.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 348555.67 | 82724.9 | 82027.8 | 88583.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1710102.08 | 402186.1 | 419792.5 | 500313.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3592157.16 | - | - | - | |||||||||||||||||
Total Investments | 476354.42 | 222022.1 | 85761.9 | 79022.5 | |||||||||||||||||
balance-sheet.row.total-debt | 651763.51 | 173030.5 | 136564.4 | 115072 | |||||||||||||||||
balance-sheet.row.net-debt | 503846.19 | 135991.9 | 101804.9 | 86491.2 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -11642.57 | -16249.7 | -83145 | -12870 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 12556.11 | 12556.1 | 10905.1 | 8983.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | -8558.55 | -60632 | 0 | -664 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 578.03 | 578 | 472.5 | 163.2 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -28544.09 | -28544.1 | -22115.2 | 14405.2 | |||||||||||||||||
cash-flows.row.account-receivables | -12922.7 | -12922.7 | -14120.2 | 8024.7 | |||||||||||||||||
cash-flows.row.inventory | -12170.48 | -12170.5 | 1347.3 | 9341.5 | |||||||||||||||||
cash-flows.row.account-payables | -9848.6 | -9848.6 | 3357.5 | 10023.5 | |||||||||||||||||
cash-flows.row.other-working-capital | 6397.69 | 6397.7 | -12699.8 | -12984.4 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 31195.44 | 87876.1 | 73080.5 | 3385.4 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4415.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 87.64 | 87.6 | 24 | -1500 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -3775.84 | -3769.8 | -0.3 | -10005.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 169.7 | 999.5 | |||||||||||||||||
cash-flows.row.other-investing-activites | 172.76 | 93.8 | 3652.9 | 41567.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -13425.02 | -13425 | -17563.7 | 7325.1 | |||||||||||||||||
cash-flows.row.debt-repayment | -31854.19 | -22634.4 | -5156.3 | -6125 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7497.6 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -397 | -31210.2 | |||||||||||||||||
cash-flows.row.dividends-paid | -1857.88 | -1133.9 | -1474.9 | -1590 | |||||||||||||||||
cash-flows.row.other-financing-activites | 54328.13 | 44384.3 | 51942.1 | 19190 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 20616.07 | 20616.1 | 44914 | -12237.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -496.29 | -496.3 | -369.4 | -93.2 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2279.12 | 2279.1 | 6178.7 | 8397.4 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 147917.32 | 37038.6 | 34759.5 | 28580.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 145638.2 | 34759.5 | 28580.8 | 20183.4 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4415.63 | -4415.6 | -20802.2 | 13403.1 | |||||||||||||||||
cash-flows.row.capital-expenditure | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | -14325.21 | -14252.3 | -42212.2 | -10333.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 801550.85 | 794713.6 | 792964.7 | 762568.1 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 590068.68 | 592891.6 | 612481.6 | 582061.3 | |||||||||||||||||
income-statement-row.row.gross-profit | 211482.17 | 201822 | 180483.1 | 180506.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 45642.2 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 43332.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 193054.13 | 190231.2 | 188031.1 | 189481.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 783122.82 | 783122.8 | 800512.7 | 771542.9 | |||||||||||||||||
income-statement-row.row.interest-income | 1731.42 | 1731.4 | 499.5 | 247.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 15380.48 | 12556.1 | -63218.7 | 8983.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 34548.17 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 18428.04 | 11590.8 | -7548 | 1552.9 | |||||||||||||||||
income-statement-row.row.income-before-tax | -16473.8 | -23311 | -83860.6 | -6129.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -740.82 | -740.8 | -715.6 | 6740.8 | |||||||||||||||||
income-statement-row.row.net-income | -7978.87 | -16249.7 | -83145 | -12870 |
Често задавани въпроси
Какво е Jeil Pharma Holdings Inc (002620.KS) общи активи?
Jeil Pharma Holdings Inc (002620.KS) общите активи са 879996990707.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 395204780875.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -933.170.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -933.170.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.010.
Какъв е общият приход на предприятието?
Общият приход е 0.023.
Каква е Jeil Pharma Holdings Inc (002620.KS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -16249744239.000.
Какъв е общият дълг на фирмата?
Общият дълг е 173030541501.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 190231187725.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 37038628042.000.